A recent legal action has been initiated against Anthropic, OpenAI, SpaceXAI, and Google, asserting that these prominent AI firms engaged in an unlawful agreement to restrain their AI development efforts.
Filed on Friday in the U.S. District Court for the Northern District of California, the lawsuit claims these leading companies violated antitrust laws by agreeing to cooperate in slowing down AI advancements, ultimately diminishing the benefits consumers receive from paid AI subscriptions.
The coordination allegedly occurred on September 12, when Dario Amodei, CEO of Anthropic, published a piece advocating for an industry-wide approach to delay progress in favor of improved safety protocols. On the same day, Sam Altman, CEO of OpenAI; Elon Musk, CEO of SpaceXAI; and Demis Hassabis, co-founder and chair of Google DeepMind, all publicly expressed their agreement with Amodei’s proposals.
The plaintiffs argue that an understanding among these key competitors to slow down their progress collectively has an anti-competitive impact on consumers. The lawsuit represents four plaintiffs, who are subscribers to AI products such as ChatGPT, Claude, Grok, or Gemini, and seeks to extend the claim to a nationwide class of paid subscribers to these services.
Lead attorney Nick Rowley stated, “AI could spiral out of human control and pose a grave threat if we let private agreements among powerful tech companies dictate safety and protocol.”
As of Saturday, representatives from Anthropic, OpenAI, Google, and SpaceXAI had not yet responded to requests for comment.
In the initial essay advocating for a slowdown, Amodei recognized potential antitrust implications, suggesting that U.S. government involvement could help facilitate discussions among different labs. He mentioned that while the government does not need to take part directly, it could provide a narrow waiver for specific safety-related conversations.
Altman responded on social media, saying that OpenAI supports a federal framework for consistent safety requirements, but asserted that they do not believe it is necessary to await an antitrust exemption or legislation before beginning their safety efforts.
Discussions regarding the pace of AI development have intensified amid rising concerns about the technology evading human oversight. Various industry leaders have long advocated for the creation of shared safety standards and collaboration to ensure safety remains a top priority.
The plaintiffs clarified that they are not opposed to the AI companies requesting Congress, the White House, or other agencies to establish regulation, nor are they against seeking an antitrust exemption. However, they recognize that achieving collaborative efforts with the federal government might prove challenging.
Former President Donald Trump has publicly dismissed calls for regulation via social media, characterizing them as part of a conspiracy, and questioned the rationale behind industry leaders advocating for regulations that might, in his view, lead to their demise.
On social media, Trump also announced plans to form an AI task force and appoint an “AI czar,” but details were scant. The Trump administration has emphasized the importance of American AI labs outperforming their Chinese counterparts, while many Democratic leaders and candidates have been advocating for comprehensive AI regulations. Conversely, Republican opinions tend to align with Trump’s stance. U.S. Senator Josh Hawley recently remarked during a Senate hearing that he sees no scenario in which he would agree to grant antitrust exemptions to “the most powerful companies in the history of the world,” cautioning that such collaboration could suppress competition.
